合成路线1
该中间体在本合成路线中的序号:
(II) The reaction of ethyl iminodiacetate (I) with 2-ethoxycarbonylacetyl chloride (II) by means ot triethylamine in refluxing methylene chloride gives ethyl N-(2-ethoxycarbonylacetyl)iminodiacetate (III), which is cyclized by means of sodium ethoxide in refluxing ethanol yielding ethyl 4-hydroxy-3-(ethoxycarbonyl)-DELTA3-pyrrolin-2-one-1-acetate (IV). The isomerization of (IV) with water in refluxing acetonitrile affords ethyl pyrrolidine-2,4-dione-1-acetate (V), which is reduced with NaBH4 in dimethoxyethane to ethyl 4-hydroxypyrrolidine-2-one-1-acetate (VI). Finally, this compound is treated with ammonia in methanol.
【1】
Pifferi, G.; Pinza, M.; Cyclic GABA [4-aminobutyric acid]-GABOB[4-amino-3-hydroxybutyric acid] analogs. I. Synthesis of new 4-hydroxy-2-pyrrolidinone derivatives. Farmaco 1977, 32, 8, 602-613.
|
【2】
Pifferi, G.; Pinza, M. (ISF SpA); Pyrrolidine derivatives. DE 2635853; FR 2320741; GB 1550160; NL 7608946; US 4118396 .
|
【3】
de Angelis, L.; Blancafort, P.; Serradell, M.N.; Castaner, J.; Oxiracetam. Drugs Fut 1980, 5, 8, 405.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
32712 |
Ethyl 2-[(2-ethoxy-2-oxoethyl)amino]acetate; Ethyl iminodiacetate
|
6290-05-7 |
C8H15NO4 |
详情 | 详情
|
(II) |
13188 |
ethyl 3-chloro-3-oxopropanoate; 2-Ethoxycarbonylacetyl chloride; Ethyl malonyl chloride
|
36239-09-5 |
C5H7ClO3 |
详情 | 详情
|
(III) |
32713 |
Ethyl 3-[bis(2-ethoxy-2-oxoethyl)amino]-3-oxopropanoate; N-(2-Ethoxycarbonylacetyl)iminodiacetate
|
|
C13H21NO7 |
详情 |
详情
|
(IV) |
32714 |
Ethyl 4-hydroxy-3-(ethoxycarbonyl)-delta3-pyrrolin-2-one-1-acetate; Ethyl 1-(2-ethoxy-2-oxoethyl)-4-hydroxy-2-oxo-2,5-dihydro-1H-pyrrole-3-carboxylate
|
|
C11H15NO6 |
详情 |
详情
|
(V) |
32715 |
Ethyl 2-(2,4-dioxo-1-pyrrolidinyl)acetate; Ethyl pyrrolidine-2,4-dione-1-acetate
|
|
C8H11NO4 |
详情 |
详情
|
(VI) |
32716 |
Ethyl 2-(4-hydroxy-2-oxo-1-pyrrolidinyl)acetate; Ethyl 4-hydroxypyrrolidine-2-one-1-acetate
|
|
C8H13NO4 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(III) The reductive cleavage of 4-phenylazo-3-methyl-5-methylaminopyrazole (I) with H2 over RaNi in ethanol gives 4-amino-3-methyl-5-methylaminopyrazole (II), which is acylated with ethoxycarbonylacetyl chloride (III) in toluene yielding 4-(ethoxycarbonylacetylamino)-3-methyl-5-methylaminopyrazole (IV). The cyclization of (IV) by means of sodium ethoxide in ethanol affords 4,8-dihydro-3,8-dimethylpyrazolo[3,4b][1,4]diazepine-5,7(1H,6H) dione (V), which is finally phenylated by a treatment with powdered Cu and potassium acetate in refluxing bromobenzene
【1】
Rackur, G.; Hoffmann, I. (Aventis SA); 4-Aryl-5,6,7,8-tetrahydropyrazolo[3,4-b]-[1,5]diazepine-1H,4H-5,7-diones and medicaments containing same. DD 152936; DE 2932835; EP 0024038; EP 0050376; JP 5603977; US 4302468 .
|
【2】
Castaner, J.; Prous, J.; Razobazam. Drugs Fut 1986, 11, 6, 465.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
24717 |
N,3-dimethyl-4-[(E)-2-phenyldiazenyl]-1H-pyrazol-5-amine
|
|
C11H13N5 |
详情 |
详情
|
(II) |
24718 |
N-(4-amino-3-methyl-1H-pyrazol-5-yl)-N-methylamine
|
|
C5H10N4 |
详情 |
详情
|
(III) |
13188 |
ethyl 3-chloro-3-oxopropanoate; 2-Ethoxycarbonylacetyl chloride; Ethyl malonyl chloride
|
36239-09-5 |
C5H7ClO3 |
详情 | 详情
|
(IV) |
24720 |
ethyl 3-[[3-methyl-5-(methylamino)-1H-pyrazol-4-yl]amino]-3-oxopropanoate
|
|
C10H16N4O3 |
详情 |
详情
|
(V) |
24721 |
3,8-dimethyl-4,8-dihydropyrazolo[3,4-b][1,4]diazepine-5,7(1H,6H)-dione
|
|
C8H10N4O2 |
详情 |
详情
|
(VI) |
13365 |
Monobromobenzene; 1-Bromobenzene;Phenylbromide;bromobenzene |
108-86-1 |
C6H5Br |
详情 | 详情
|
合成路线3
该中间体在本合成路线中的序号:
(VII) The condensation of 2-methoxyphenol (I) with 2-bromoethanal dimethylacetal (II) by means of K2CO3 in hot DMF gives 2-(2-methoxyphenoxy)ethanal dimethylacetal (III), which is hydrolyzed to the corresponding free aldehyde (IV) with 2N H2SO4 in methanol. The cyclization of (IV) with cysteamine (V) by means of potassium acetate in water affords 2-(2-methoxyphenoxymethyl)thiazolidine (VI), which is finally condensed with ethoxymalonyl chloride (VII) by means of KHCO3 in ethyl acetate.
【1】
Gandolfi, C.A.; Spinelli, S.; Tofanetti, O.; Russo, R.; Tognella, S. (Boehringer Ingelheim Italia SpA); Antitussive and mucus regulating 2-substituted thiazolidines. AU 8545242; EP 0169581; ES 8605249; GB 2164333; GB 2177690; JP 1986063669; US 4857643 . |
【2】
Gandolfi, C.A.; Di Domenico, R.; Spinelli, S.; Lumachi, B.; Gallico, L.; Tognella, S. (Boehringer Ingelheim Italia SpA); Beta-carbonyl-carboxyamides of 1,3-thiazolidines. EP 0333080; JP 1991504123; US 5206254 .
|
【3】
De Angelis, L.; Moguisteine. Drugs Fut 1991, 16, 7, 618.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13182 |
Guaiacol; 2-Methoxyphenol
|
90-05-1 |
C7H8O2 |
详情 | 详情
|
(II) |
13183 |
2-Bromo-1,1-dimethoxyethane; 2-Bromo-1-methoxyethyl methyl ether; Bromoacetaldehyde dimethyl acetal
|
7252-83-7 |
C4H9BrO2 |
详情 | 详情
|
(III) |
13184 |
1-(2,2-Dimethoxyethoxy)-2-methoxybenzene; 2-(2,2-Dimethoxyethoxy)phenyl methyl ether
|
|
C11H16O4 |
详情 |
详情
|
(IV) |
13185 |
2-(2-Methoxyphenoxy)acetaldehyde
|
|
C9H10O3 |
详情 |
详情
|
(V) |
13186 |
2-Aminoethanethiol; 2-Amino-1-ethanethiol; 2-Aminoethylhydrosulfide; Cysteamine
|
60-23-1 |
C2H7NS |
详情 | 详情
|
(VI) |
13187 |
2-[(2-Methoxyphenoxy)methyl]-1,3-thiazolidine; 2-Methoxyphenyl 1,3-thiazolidin-2-ylmethyl ether
|
|
C11H15NO2S |
详情 |
详情
|
(VII) |
13188 |
ethyl 3-chloro-3-oxopropanoate; 2-Ethoxycarbonylacetyl chloride; Ethyl malonyl chloride
|
36239-09-5 |
C5H7ClO3 |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(IV) Tetrahydrofuranone (XIII): The Grignard condensation of isobutyraldehyde (I) with vinylmagnesium bromide (II) in THF gives the magnesium alcoholate (III), which is condensed with ethyl malonyl chloride (IV) in the same solvent, yielding the mixed ester (V). Treatment of (V) with Ti(OEt)4 at 190 C affords 6-methyl-4(E)-heptenoic acid methyl ester (VI), which by reaction with (R,R)-(-)-pseudoephedrine (VII), oxalyl chloride and DMF in benzene gives the amide (VIII). The regiocontrolled addition of 4-fluorobenzyl chloride (IX) to the chiral amide (VIII) by means of BuLi and LiCl in THF yields the 2(S)-(4-fluorobenzyl)heptanamide (X), which by reaction with NBS in THF/water/acetic acid at 0 C, followed by reflux for 45 min, affords 5(S)-[1(R)-bromo-2-methylpropyl]-3(R)-(4-fluorobenzyl)tetrahydrofuran-2-one (XI). The reaction of (XI) with NaN3 in DMF gives the corresponding azide (XII), which is reduced with H2 over Pd/C, and the resulting amine is protected with tert-butoxycarbonyl anhydride to obtain the desired tetrahydrofuranone (XIII).
【1】
Worland, S.T.; Ferre, R.A.; Patick, A.K.; Prins, T.J.; Meador, J.W. III; Zhou, R.; Dragovich, P.S.; Fuhrman, S.A.; Matthews, D.A.; Ford, C.E.; Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics. J Med Chem 1999, 42, 7, 1203. |
【2】
Graul, A.; Castañer, J.; AG-7088. Drugs Fut 2000, 25, 1, 9.
|
【3】
Meyer, M.D.; Daanen, J.F.; Ehrlich, P.P.; Ralston, J.W. (Abbott Laboratories Inc.); 3-Phenylpyrrole alpha-1 adrenergic cpds.. WO 9957122 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13226 |
2-Methylpropanal; Isobutyraldehyde
|
78-84-2 |
C4H8O |
详情 | 详情
|
(II) |
16524 |
bromo(vinyl)magnesium
|
1826-67-1 |
C2H3BrMg |
详情 | 详情
|
(III) |
32096 |
4-Methyl-1-penten-3-ol bromomagnesium salt
|
|
C6H11BrMgO |
详情 |
详情
|
(IV) |
13188 |
ethyl 3-chloro-3-oxopropanoate; 2-Ethoxycarbonylacetyl chloride; Ethyl malonyl chloride
|
36239-09-5 |
C5H7ClO3 |
详情 | 详情
|
(V) |
32097 |
1-ethyl 3-(1-isopropyl-2-propenyl) malonate
|
|
C11H18O4 |
详情 |
详情
|
(VI) |
32098 |
methyl (E)-6-methyl-4-heptenoate
|
|
C9H16O2 |
详情 |
详情
|
(VII) |
32104 |
(1R,2R)-2-amino-1-phenyl-1-propanol
|
|
C9H13NO |
详情 |
详情
|
(VIII) |
32099 |
(E)-N-[(1R,2R)-2-hydroxy-1-methyl-2-phenylethyl]-6-methyl-4-heptenamide
|
|
C17H25NO2 |
详情 |
详情
|
(IX) |
24611 |
1-(bromomethyl)-4-fluorobenzene
|
459-46-1 |
C7H6BrF |
详情 | 详情
|
(X) |
32100 |
(2S,4E)-2-(4-fluorobenzyl)-N-[(1R,2R)-2-hydroxy-1-methyl-2-phenylethyl]-6-methyl-4-heptenamide
|
|
C24H30FNO2 |
详情 |
详情
|
(XI) |
32101 |
(3R,5S)-5-[(1R)-1-bromo-2-methylpropyl]-3-(4-fluorobenzyl)dihydro-2(3H)-furanone
|
|
C15H18BrFO2 |
详情 |
详情
|
(XII) |
32102 |
(3R,5S)-5-[(1S)-1-azido-2-methylpropyl]-3-(4-fluorobenzyl)dihydro-2(3H)-furanone
|
|
C15H18FN3O2 |
详情 |
详情
|
(XIII) |
32103 |
tert-butyl (1S)-1-[(2S,4R)-4-(4-fluorobenzyl)-5-oxotetrahydro-2-furanyl]-2-methylpropylcarbamate
|
|
C20H28FNO4 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(VII) 2-Cyanophenol (I) was condensed with 2-bromo-4'-methoxyacetophenone (II) in the presence of K2CO3 in acetone to give aminobenzofuran (III). This was acylated with trifluoroacetic anhydride, and the resulting trifluoroacetamide (IV) was alkylated with 2,5-dimethoxybenzyl chloride (V) under phase-transfer conditions to afford monobenzylated compound (VI). The benzofuro[3,2-b]pyridine nucleus was formed by acylation of the secondary amine group of (VI) with ethyl malonyl chloride (VII) to give (VIII) followed by an intramolecular Knoevenagel condensation over silica gel in refluxing CH2Cl2 to give (IX). Alkaline hydrolysis of the ester function of (IX) then provided the corresponding carboxylic acid.
【1】
Mederski, W.K.R.; Wilm, C.; Schmitges, C.-J.; Oswald, M.; Dorsch, D.; Christadler, M.; Benzofuro[3,2-b]pyridines as mixed ETA/ETB and selective ETB endothelin receptor antagonists. Bioorg Med Chem Lett 1999, 9, 4, 619.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
21990 |
2-hydroxybenzonitrile
|
611-20-1 |
C7H5NO |
详情 | 详情
|
(II) |
21991 |
2-Methoxyphenacyl bromide; 2-bromo-1-(4-methoxyphenyl)-1-ethanone
|
2632-13-5 |
C9H9BrO2 |
详情 | 详情
|
(III) |
21992 |
(3-amino-1-benzofuran-2-yl)(4-methoxyphenyl)methanone
|
|
C16H13NO3 |
详情 |
详情
|
(IV) |
21993 |
2,2,2-trifluoro-N-[2-(4-methoxybenzoyl)-1-benzofuran-3-yl]acetamide
|
|
C18H12F3NO4 |
详情 |
详情
|
(V) |
21994 |
2-(chloromethyl)-4-methoxyphenyl methyl ether; 2-(chloromethyl)-1,4-dimethoxybenzene
|
3840-27-5 |
C9H11ClO2 |
详情 | 详情
|
(VI) |
21995 |
[3-[(2,5-dimethoxybenzyl)amino]-1-benzofuran-2-yl](4-methoxyphenyl)methanone
|
|
C25H23NO5 |
详情 |
详情
|
(VII) |
13188 |
ethyl 3-chloro-3-oxopropanoate; 2-Ethoxycarbonylacetyl chloride; Ethyl malonyl chloride
|
36239-09-5 |
C5H7ClO3 |
详情 | 详情
|
(VIII) |
21997 |
ethyl 3-[(2,5-dimethoxybenzyl)[2-(4-methoxybenzoyl)-1-benzofuran-3-yl]amino]-3-oxopropanoate
|
|
C30H29NO8 |
详情 |
详情
|
(IX) |
21998 |
ethyl 1-(2,5-dimethoxybenzyl)-4-(4-methoxyphenyl)-2-oxo-1,2-dihydro[1]benzofuro[3,2-b]pyridine-3-carboxylate
|
|
C30H27NO7 |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(V) Reaction of 2-amino-6-chlorobenzoic acid (I) with phosgene and NaHCO3 in dioxane gives 5-chloroisatoic anhydride (II), which is methylated by means of iodomethane and NaH in DMF to yield 5-chloro-1-methylisatoic anhydride (III). Finally, anhydride (III) is condensed with the malonic monoamide (IV) by means of NaH in hot dimethylacetamide.
Alternatively, condensation of anhydride (III) with ethoxy malonyl chloride (V) by means of NaOMe and triethylamine in dichloromethane affords 5-chloro-4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3- carboxylic acid ethyl ester (VI), which is finally condensed with N-ethylaniline (VII) in refluxing toluene.
Alternatively, ester (VI) is hydrolyzed by means of concentrated HCl in hot Ac2O to give the carboxylic acid (VIII), which is finally condensed with N-ethylaniline (VII) by means of SOCl2 and TEA in dichloromethane
【1】
Sorbera, L.A.; Castaner, J.; Laquinimod. Drugs Fut 2003, 28, 11, 1059.
|
【2】
Bjork, A.; Jonsson, S.; Fex, T.; Hedlund, G. (Active Biotech AB); Quinoline derivs.. EP 1073639; JP 2002513006; US 6077851; WO 9955678 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
63056 |
2-amino-6-chlorobenzoic acid
|
|
C7H6ClNO2 |
详情 |
详情
|
(II) |
58824 |
5-chloro-2H-3,1-benzoxazine-2,4(1H)-dione
|
|
C8H4ClNO3 |
详情 |
详情
|
(III) |
58825 |
5-chloro-1-methyl-2H-3,1-benzoxazine-2,4(1H)-dione
|
|
C9H6ClNO3 |
详情 |
详情
|
(IV) |
58826 |
ethyl 3-(ethylanilino)-3-oxopropanoate
|
|
C13H17NO3 |
详情 |
详情
|
(V) |
13188 |
ethyl 3-chloro-3-oxopropanoate; 2-Ethoxycarbonylacetyl chloride; Ethyl malonyl chloride
|
36239-09-5 |
C5H7ClO3 |
详情 | 详情
|
(VI) |
63057 |
ethyl 5-chloro-4-hydroxy-1-methyl-2-oxo-1,2-dihydro-3-quinolinecarboxylate
|
|
C13H12ClNO4 |
详情 |
详情
|
(VII) |
63058 |
N-ethyl-N-phenylamine; N-ethylaniline
|
|
C8H11N |
详情 |
详情
|
(VIII) |
63059 |
5-chloro-4-hydroxy-1-methyl-2-oxo-1,2-dihydro-3-quinolinecarboxylic acid
|
|
C11H8ClNO4 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(XLIV)
【1】
Zhao MM, McNamara JM, Ho GJ, et aL 2002. Practical aaymmetric synthesis of aprepitant,apotmt Human NK-1 receptor anUylonist, viaa stereoselective lewis acid-catalyzed trans aoetalization rraction- J Org
Chem, 67 (19)t 6743~6747 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XLIV) |
13188 |
ethyl 3-chloro-3-oxopropanoate; 2-Ethoxycarbonylacetyl chloride; Ethyl malonyl chloride
|
36239-09-5 |
C5H7ClO3 |
详情 | 详情
|
(XLVI) |
66104 |
2-oxo-2-((1-phenylethyl)amino)acetic acid |
|
C10H11NO3 |
详情 | 详情
|
(XLVII) |
11972 |
(1R)-3-(Methylamino)-1-phenyl-1-propanol; (R)-3-Hydroxy-N-methyl-3-phenyl propylamine
|
42142-52-9 |
C10H15NO |
详情 | 详情
|
(XLVIII) |
66105 |
3-(4-fluorophenyl)-4-((S)-1-phenylethyl)morpholin-2-one hydrochloride |
|
C18H19FClNO2 |
详情 | 详情
|
(XLIX) |
66106 |
3-(4-fluorophenyl)-4-((R)-1-phenylethyl)morpholin-2-ol |
|
C18H20FNO2 |
详情 | 详情
|
(L) |
66107 |
(2S)-3-(4-fluorophenyl)-4-((S)-1-phenylethyl)morpholin-2-yl 2,2,2-trichloroacetimidate |
|
C20H20FCl3N2O2 |
详情 | 详情
|
(LI) |
66108 |
(R)-1-(3,5-(trifluoromethyl)phenyl)ethanol |
|
C10H8F6O |
详情 | 详情
|
(LII) |
66109 |
(3R)-2-(1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-((R)-1-phenylethyl)morpholine |
|
C28H26F7NO2 |
详情 | 详情
|
(XLI) |
66101 |
(2R)-2-(1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine |
|
C20H18F7NO2 |
详情 | 详情
|
(LIII) |
66110 |
6-(1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-5-(4-fluorophenyl)-3,6-dihydro-2H-1,4-oxazine |
|
C20H16F7NO2 |
详情 | 详情
|
(LIV) |
66111 |
2-(1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine hydrochloride |
|
C20H19ClF7NO2 |
详情 | 详情
|
(X) |
18999 |
4-Fluorophenylacetic acid; 2-(4-Fluorophenyl)acetic acid
|
405-50-5 |
C8H7FO2 |
详情 | 详情
|
(XXVI) |
44196 |
5-(chloromethyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
|
|
C3H4ClN3O |
详情 |
详情
|
(XLIII) |
66103 |
1-(4-fluorophenyl)-2,2-dihydroxyethanone |
|
C8H7FO3 |
详情 | 详情
|
(XLV) |
10039 |
(1R)-1-Phenylethylamine; (1R)-1-Phenyl-1-ethanamine.; L-alpha-Phenylethylamine
|
3886-69-9 |
C8H11N |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(XXV) Chlorination of 2-chloro-5-nitrobenzenesulfonic acid (XIV) with SOCl2 in refluxing DMF gives the sulfonyl chloride (XV), which is converted to the corresponding sulfonamide (XVI) by treatment with NH4OH in toluene/THF. Amination of the chloro sulfonamide (XVI) with (NH4)2CO3 and NH4OH in the presence of CuSO4 at 118 °C leads to 2-amino-5-nitrobenzenesulfonamide (XVII). Alternatively, chlorination of 2-amino-5-nitrobenzenesulfonic acid (XVIII) using POCl3 in sulfolane at 110-120 °C provides the corresponding sulfonyl chloride (XIX), which is treated with NH4OH to yield sulfonamide (XVII). Reduction of the nitro moiety of compound (XVII) with H2 over Pd/C in the presence of MsOH in EtOH/H2O at 55 °C affords 2,5-diaminobenzenesulfonamide mesylate (XX), which can also be obtained by chloride substitution in 2-chloro-5-nitrobenzenesulfonamide (XVI) with benzylamine by means of Et3N in acetonitrile at 92 °C, followed by hydrogenolysis of the resulting 2-(benzylamino)-5-nitrobenzenesulfonamide (XXI) over Pd/C in the presence of MsOH in THF/EtOH/H2O. Selective N-sulfonylation of diamine (XX) with methanesulfonyl chloride (XXII) and pyridine in CH2Cl2 or acetonitrile gives rise to 2-amino-5-(methylsulfonamido)benzenesulfonamide (XXIII), which is then condensed with either methyl malonyl chloride (XXIV) in THF or ethyl malonyl chloride (XXV) in DMF/Et2O or DMA , yielding amides (XXVI) or (XXVII). Finally, carbamoyl sulfonamides (XXVI) and (XXVII) are cyclized and simultaneously hydrolyzed by treatment with NaOH (XII) .
【1】
Tran, C.V., Ruebsam, F., Murphy, D.E. et al. (Anadys Pharmaceuticals, Inc.). 5,6-Dihydro-1H-pyridin-2-one compounds. CA 2682584, EP 2129224, JP 2010523586, US 2010034773, US 7939524, US 8101800, US 2012130068, US 8236948, WO 2008124450. |
【2】
Dragovich, P.S., Thompson, P.A., Ruebsam, F. (Anadys Pharmaceuticals, Inc.). A method of inhibiting hepatitis C virus by combination of a 5,6-dihydro-1H-pyridin-2-one and one or more additional antiviral compounds. EP 2346329, US 2011229438, WO 2010042834. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XII) |
68662 |
2-(7-(methylsulfonamido)-1,1-dioxido-4H-benzo[e][1,2,4]thiadiazin-3-yl)acetic acid |
|
C10H11N3O6S2 |
详情 | 详情
|
(XIV) |
68665 |
2-chloro-5-nitrobenzenesulfonic acid;2-Chloro-5-nitrobenzene sulfonic acid;p-Nitrochlorobenzene-o-sulfonic acid;2-chloro-5-nitro-Benzenesulfonic acid;2-chloro-5-nitrobenzenesulphonic acid |
96-73-1 |
C6H4ClNO5S |
详情 | 详情
|
(XV) |
43034 |
2-chloro-5-nitrobenzenesulfonyl chloride;2-Chloro-5-nitro-benzenesulfonyl chloride;2-Chloro-5-nitrophenylsulfonyl chloride;6-Chloro-3-nitrobenzenesulfonyl chloride |
4533-95-3 |
C6H3Cl2NO4S |
详情 | 详情
|
(XVI) |
43035 |
2-chloro-5-nitrobenzenesulfonamide
|
96-72-0 |
C6H5ClN2O4S |
详情 | 详情
|
(XVII) |
68666 |
2-amino-5-nitrobenzenesulfonamide |
|
C6H7N3O4S |
详情 | 详情
|
(XVIII) |
68668 |
2-amino-5-nitrobenzenesulfonic acid |
96-75-3 |
C6H6N2O5S |
详情 | 详情
|
(XIX) |
68667 |
2-amino-5-nitrobenzene-1-sulfonyl chloride |
|
C6H5ClN2O4S |
详情 | 详情
|
(XX) |
68669 |
2,5-diaminobenzenesulfonamide mesylate;2,5-diaminobenzenesulfonamide methanesulfonate |
|
C6H9N3O2S.CH4O3S |
详情 | 详情
|
(XXI) |
68670 |
2-(benzylamino)-5-nitrobenzenesulfonamide |
|
C13H13N3O4S |
详情 | 详情
|
(XXII) |
13467 |
Methanesulfonyl chloride;Mesyl chloride;Methylsulfonyl chloride;Methanesulfonic acid chloride;Methanesulfonyl chloride;Methanesulphonyl chloride |
124-63-0 |
CH3ClO2S |
详情 | 详情
|
(XXIII) |
68671 |
2-amino-5-(methylsulfonamido)benzenesulfonamide |
|
C7H11N3O4S2 |
详情 | 详情
|
(XXIV) |
50272 |
Malonic acid monomethyl ester chloride; Methyl (chloroformyl)acetate; Methyl malonyl chloride
;Methyl 3-chloro-3-oxopropionate |
37517-81-0 |
C4H5ClO3 |
详情 | 详情
|
(XXV) |
13188 |
ethyl 3-chloro-3-oxopropanoate; 2-Ethoxycarbonylacetyl chloride; Ethyl malonyl chloride
|
36239-09-5 |
C5H7ClO3 |
详情 | 详情
|
(XXVI) |
68672 |
methyl 3-((4-(methylsulfonamido)-2-sulfamoylphenyl)amino)-3-oxopropanoate |
|
C11H15N3O7S2 |
详情 | 详情
|
(XXVII) |
68673 |
ethyl 3-((4-(methylsulfonamido)-2-sulfamoylphenyl)amino)-3-oxopropanoate |
|
C12H17N3O7S2 |
详情 | 详情
|